A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously

PHASE4CompletedINTERVENTIONAL
Enrollment

657

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
PainAnalgesia, Patient-ControlledPain, Postoperative
Interventions
DRUG

IONSYS (fentanyl HCl) Iontophoretic TransdermalSystem

40 µg fentanyl on-demand (240µg/hr) or a maximum of 80 doses (3.2 mg) per day

DRUG

IV Morphine Patient-Controlled Analgesia (IV PCA)

20mg/2hr (240 mg during 24 hours)

Trial Locations (44)

Unknown

Vienna

Brussels

Ghent

Leuven

Aalborg

Kÿbenhavn Nv N/A

Kÿbenhavn Ÿ

Odense C

Ÿrhus C

Boulogne-Billancourt

Le Kremlin-Bicêtre

Lille

Montpellier

Nice

Paris

Rennes

Suresnes

Aachen

Bochum

Bonn

Frankfurt am Main

Halle

Hamburg

Jena

Kiel

Kÿln

Mainz

Marburg

Ulm

Cork

Madrid

Gothenburg

Huddinge

Linköpng N/A

Örebro

Stockholm

Geneva

Lucerne

Sankt Gallen

Zurich

Edinburgh

London

N/a N/a

Salford

Sponsors
All Listed Sponsors
collaborator

Alza Corporation, DE, USA

INDUSTRY

lead

Janssen-Cilag International NV

INDUSTRY